AST-202

N/A

Report date: 2024/01/05 13:22:10
NME

Base Information

Drug NameAST-202
Drug Alias NameAST 202 Aptamer drug conjugate(Aptamer Sciences)AST-202AST-202 ApDC
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionInterleukin-2 receptor alpha chain antagonists
TargetsInterleukin-2 receptor alpha chain
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAptamer Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesAptamer Sciences Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A